2024-04-17 13:49 | CC:CRDL | Cardiol Therapeutics Inc | 2.415 | Warrants Expire110 | Cardiol Therapeutics warrants to expire May 13 |
2024-04-02 09:26 | CC:CRDL | Cardiol Therapeutics Inc | 2.58 | News Release200 | Cardiol Therapeutics recaps 2023 operations |
2024-04-01 19:04 | CC:CRDL | Cardiol Therapeutics Inc | 2.58 | SEDAR Annual Report803 | SEDAR Annual Report |
2024-04-01 18:57 | CC:CRDL | Cardiol Therapeutics Inc | 2.58 | SEDAR MD & A815 | SEDAR MD & A |
2024-04-01 18:45 | CC:CRDL | Cardiol Therapeutics Inc | 2.58 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-02-21 11:23 | CC:CRDL | Cardiol Therapeutics Inc | 2.25 | News Release200 | Cardiol completes patient enrolment for CardiolRx study |
2024-02-15 09:28 | CC:CRDL | Cardiol Therapeutics Inc | 1.42 | News Release200 | Cardiol receives orphan drug designation for CardiolRx |
2024-01-24 11:08 | CC:CRDL | Cardiol Therapeutics Inc | 1.52 | News Release200 | Cardiol regains Nasdaq listing standard compliance |
2024-01-09 11:35 | CC:CRDL | Cardiol Therapeutics Inc | 1.36 | News Release200 | Cardiol enrolls over 50% of patients in Archer study |
2023-12-05 11:11 | CC:CRDL | Cardiol Therapeutics Inc | 1.29 | News Release200 | Cardiol adds Mass. General Hospital to CardiolRx study |
2023-11-16 09:18 | CC:CRDL | Cardiol Therapeutics Inc | 1.14 | News Release200 | Cardiol presents CardiolRx study results at MPD2023 |
2023-11-14 16:45 | CC:CRDL | Cardiol Therapeutics Inc | 1.19 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-14 16:41 | CC:CRDL | Cardiol Therapeutics Inc | 1.19 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-01 10:27 | CC:CRDL | Cardiol Therapeutics Inc | 1.17 | News Release200 | Cardiol enrolls over 50% of patients in CardiolRx study |
2023-10-20 17:16 | CC:CRDL | Cardiol Therapeutics Inc | 0.94 | News Release200 | Cardiol's share price sinks below Nasdaq $1 (U.S.) min. |
2023-10-10 10:00 | CC:CRDL | Cardiol Therapeutics Inc | 1.18 | News Release200 | Cardiol's CRD-38 study shows cardioprotective effects |
2023-09-19 10:39 | CC:CRDL | Cardiol Therapeutics Inc | 1.31 | News Release200 | Cardiol expects full enrolment in Archer phase 2 trial |
2023-08-10 17:07 | CC:CRDL | Cardiol Therapeutics Inc | 1.31 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-08-08 12:53 | CC:CRDL | Cardiol Therapeutics Inc | 1.60 | News Release200 | Cardiol Therapeutics meets Nasdaq minimum bid price |
2023-06-29 16:13 | CC:CRDL | Cardiol Therapeutics Inc | 1.06 | News Release200 | Cardiol shareholders elect eight directors at AGM |
2023-06-27 12:38 | CC:CRDL | Cardiol Therapeutics Inc | 1.05 | News Release200 | Cardiol Therapeutics to hold virtual AGM June 28 |
2023-05-15 16:20 | CC:CRDL | Cardiol Therapeutics Inc | 0.74 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-15 16:20 | CC:CRDL | Cardiol Therapeutics Inc | 0.74 | SEDAR MD & A815 | SEDAR MD & A |